17β-Methyl-3-methoxy-18-nor-oestra-1,3,5(10),13(14)-tetraen (114297-13-1)
Identification |
Properties |
Safety Data |
|
|
Other Product
- (17β)-13-Ethyl-3-Methoxygona-1,3,5(10),15-tetraen-17-ol
- 1/C14H15O3P/c15-18(16-11-13-7-3-1-4-8-13)17-12-14-9-5-2-6-10-14/h1-10,18H,11-12H
- 1/C14H9Br2O2P/c15-11-6-8-13(17-11)19(10-4-2-1-3-5-10)14-9-7-12(16)18-14/h1-9
- 1/C14H19NO2S/c16-18-15(10-12-6-2-1-3-7-12)11-13-8-4-5-9-14(13)17-18/h1-3,6-7,13-14H,4-5,8-11H2/t13-,14-,18?/m1/s
- 18-Nor-17β-estradiol
- l-3-Methoxy-13β-ethyl-gona-1,3,5(10),8-tetraen-17β-ol-hydrogensuccinat
- 3-methoxy-13β-methylgona-1,3,5(10),9(11)-tetraen-17β-yl acetate
- 1/C11H14N2O6/c1-17-7(14)4-12-2-3-13-9(10(12)15)8-6(19-13)5-18-11(8)16/h6,8-9H,2-5H2,1H
- Ibogamine-18-carboxylicacid, 13-methoxy-14-[(3a)-17-methoxy-17-oxovobasan-3-yl]-, methyl ester
- 1/C15H10O4/c16-11-7-3-1-5-9(11)15-14(18)13(17)10-6-2-4-8-12(10)19-15/h1-8,16,18
- 1/C12H10N4O3/c1-3-19-12(18)10-9(7(2)17)6-14-11-8(4-13)5-15-16(10)11/h5-6H,3H2,1-2H
- 1/C14H16O4/c1-5-10-12-9(14(15)18-10)6-7-11(16-4)13(12)17-8(2)3/h5-8,10H,1H2,2-4H
- 1/C16H14ClNO3/c1-10-6-12(17)7-11(15(10)19)8-18-9-21-16(20)13-4-2-3-5-14(13)18/h2-7,19H,8-9H2,1H
- A-Nor-17β-acetyloxy-5-vinyl-5α-androstan-3-one
- 17β-Acetoxy-3-oxo-14α-methyl-A-nor-5β-androstan
- 1/C19H24N2O2/c1-12(2)14-8-6-9-15(13(3)4)17(14)21-19(22)18-16(23-5)10-7-11-20-18/h6-13H,1-5H3,(H,21,22
- 1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
- 3-Methoxy-18-methylestra-1,3,5(10),8-tetraen-17-ethylene ketal
- Spiro[cyclohexane-1,2'-[9,4](epoxypentadeca[1,11,- 13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]- imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)- 1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'- methoxy-7',9',15',17',19',21',25'-heptamethyl-,(9'S,12'E,14'S,15'R,16'S,17'R,18'R,19'R,20'S,- 21'S,22'E,24'Z)-
- Gona-1,3,5(10),8-tetraen-17b-ol, 13-hexadecyl-3-methoxy-(7CI,8CI)